Literature DB >> 35544951

DOCKopathies: A systematic review of the clinical pathologies associated with human DOCK pathogenic variants.

Adrienne Samani1, Katherine G English1, Michael A Lopez1, Camille L Birch2,3, Donna M Brown2,3, Gurpreet Kaur2,3, Elizabeth A Worthey2,3, Matthew S Alexander1,4,5,6,7.   

Abstract

The Dedicator of Cytokinesis (DOCK) family (DOCK1-11) of genes are essential mediators of cellular migration, growth, and fusion in a variety of cell types and tissues. Recent advances in whole-genome sequencing of patients with undiagnosed genetic disorders have identified several rare pathogenic variants in DOCK genes. We conducted a systematic review and performed a patient database and literature search of reported DOCK pathogenic variants that have been identified in association with clinical pathologies such as global developmental delay, immune cell dysfunction, muscle hypotonia, and muscle ataxia among other categories. We then categorized these pathogenic DOCK variants and their associated clinical phenotypes under several unique categories: developmental, cardiovascular, metabolic, cognitive, or neuromuscular. Our systematic review of DOCK variants aims to identify and analyze potential DOCK-regulated networks associated with neuromuscular diseases and other disease pathologies, which may identify novel therapeutic strategies and targets. This systematic analysis and categorization of human-associated pathologies with DOCK pathogenic variants is the first report to the best of our knowledge for a unique class in this understudied gene family that has important implications in furthering personalized genomic medicine, clinical diagnoses, and improve targeted therapeutic outcomes across many clinical pathologies.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  DOCK; hypotonia; intellectual disability; skeletal muscle

Mesh:

Substances:

Year:  2022        PMID: 35544951      PMCID: PMC9357139          DOI: 10.1002/humu.24398

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.700


  27 in total

1.  Variants in DOCK3 cause developmental delay and hypotonia.

Authors:  Kimberly Wiltrout; Alejandro Ferrer; Ingrid van de Laar; Kazuhiko Namekata; Takayuki Harada; Eric W Klee; Michael T Zimmerman; Margot A Cousin; Jennifer L Kempainen; Dusica Babovic-Vuksanovic; Marjon A van Slegtenhorst; Coranne D Aarts-Tesselaar; Rhonda E Schnur; Marisa Andrews; Marwan Shinawi
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

Review 2.  DOCK8 deficiency: Insights into pathophysiology, clinical features and management.

Authors:  Catherine M Biggs; Sevgi Keles; Talal A Chatila
Journal:  Clin Immunol       Date:  2017-06-15       Impact factor: 3.969

3.  DOCK3-related neurodevelopmental syndrome: Biallelic intragenic deletion of DOCK3 in a boy with developmental delay and hypotonia.

Authors:  Aiko Iwata-Otsubo; Alyssa L Ritter; Brooke Weckselbatt; Nicole R Ryan; David Burgess; Laura K Conlin; Kosuke Izumi
Journal:  Am J Med Genet A       Date:  2017-11-12       Impact factor: 2.802

4.  Polarized Dock Activity Drives Shh-Mediated Axon Guidance.

Authors:  Shirin Makihara; Steves Morin; Julien Ferent; Jean-François Côté; Patricia T Yam; Frédéric Charron
Journal:  Dev Cell       Date:  2018-08-02       Impact factor: 12.270

5.  MOCA induces membrane spreading by activating Rac1.

Authors:  Kazuhiko Namekata; Yasushi Enokido; Kazu Iwasawa; Hideo Kimura
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

Review 6.  Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.

Authors:  Annemieke Aartsma-Rus; Ivo Fokkema; Jan Verschuuren; Ieke Ginjaar; Judith van Deutekom; Gert-Jan van Ommen; Johan T den Dunnen
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

7.  Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.

Authors:  Kerry Dobbs; Cecilia Domínguez Conde; Shen-Ying Zhang; Silvia Parolini; Magali Audry; Janet Chou; Emma Haapaniemi; Sevgi Keles; Ivan Bilic; Satoshi Okada; Michel J Massaad; Samuli Rounioja; Adel M Alwahadneh; Nina K Serwas; Kelly Capuder; Ergin Çiftçi; Kerstin Felgentreff; Toshiro K Ohsumi; Vincent Pedergnana; Bertrand Boisson; Şule Haskoloğlu; Arzu Ensari; Michael Schuster; Alessandro Moretta; Yuval Itan; Ornella Patrizi; Flore Rozenberg; Pierre Lebon; Janna Saarela; Mikael Knip; Slavé Petrovski; David B Goldstein; Roberta E Parrott; Berna Savas; Axel Schambach; Giovanna Tabellini; Christoph Bock; Talal A Chatila; Anne Marie Comeau; Raif S Geha; Laurent Abel; Rebecca H Buckley; Aydan İkincioğulları; Waleed Al-Herz; Merja Helminen; Figen Doğu; Jean-Laurent Casanova; Kaan Boztuğ; Luigi D Notarangelo
Journal:  N Engl J Med       Date:  2015-06-18       Impact factor: 91.245

Review 8.  Analysis and Interpretation of the Impact of Missense Variants in Cancer.

Authors:  Maria Petrosino; Leonore Novak; Alessandra Pasquo; Roberta Chiaraluce; Paola Turina; Emidio Capriotti; Valerio Consalvi
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

9.  Autism-like social deficit generated by Dock4 deficiency is rescued by restoration of Rac1 activity and NMDA receptor function.

Authors:  Daji Guo; Yinghui Peng; Laijian Wang; Xiaoyu Sun; Xiaojun Wang; Chunmei Liang; Xiaoman Yang; Shengnan Li; Junyu Xu; Wen-Cai Ye; Bin Jiang; Lei Shi
Journal:  Mol Psychiatry       Date:  2019-08-06       Impact factor: 15.992

10.  ClinVar: public archive of interpretations of clinically relevant variants.

Authors:  Melissa J Landrum; Jennifer M Lee; Mark Benson; Garth Brown; Chen Chao; Shanmuga Chitipiralla; Baoshan Gu; Jennifer Hart; Douglas Hoffman; Jeffrey Hoover; Wonhee Jang; Kenneth Katz; Michael Ovetsky; George Riley; Amanjeev Sethi; Ray Tully; Ricardo Villamarin-Salomon; Wendy Rubinstein; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2015-11-17       Impact factor: 16.971

View more
  1 in total

1.  Dock10 Regulates Cardiac Function under Neurohormonal Stress.

Authors:  Liad Segal; Sharon Etzion; Sigal Elyagon; Moran Shahar; Hadar Klapper-Goldstein; Aviva Levitas; Michael S Kapiloff; Ruti Parvari; Yoram Etzion
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.